Narmada Gelatines Ltd

Narmada Gelatine Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Narmada Gelatines Ltd

₹ 505 1.02%
03 Jul - close price
narmadagelatines.com BSE: 526739
About

Incorporated in 1969, Narmada Gelatines Ltd manufactures and sells Gelatine and Ossein[1]

Key Points

Business Overview:[1]
Company is engaged in the manufacture
of ossein and gelatin. It is located at Jabalpur
and has access to its main and essential
inputs of crushed bones, acid, lime and
water

Website BSE
  • Market Cap ₹ 306 Cr.
  • Current Price ₹ 505
  • High / Low ₹ 530 / 327
  • Stock P/E 9.70
  • Book Value ₹ 240
  • Dividend Yield 1.98 %
  • ROCE 29.5 %
  • ROE 23.7 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
48 50 46 51 57 62
41 42 38 42 46 48
Operating Profit 7 7 8 9 11 14
OPM % 14% 15% 16% 18% 19% 22%
0 1 1 1 1 1
Interest 1 0 0 0 0 0
Depreciation 1 1 1 1 1 1
Profit before tax 6 7 8 9 11 13
Tax % 25% 17% 22% 27% 22% 23%
4 6 6 7 8 10
EPS in Rs 7.31 9.97 9.88 11.39 13.89 16.88
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
189 215
164 174
Operating Profit 25 41
OPM % 13% 19%
2 4
Interest 1 1
Depreciation 2 3
Profit before tax 24 41
Tax % 24% 24%
18 31
EPS in Rs 29.80 52.05
Dividend Payout % 34% 21%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 14%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 81%
Stock Price CAGR
10 Years: 13%
5 Years: 21%
3 Years: 7%
1 Year: 34%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 24%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
Equity Capital 6 6
Reserves 114 139
13 8
27 26
Total Liabilities 160 179
33 41
CWIP 7 5
Investments 42 45
78 87
Total Assets 160 179

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
17 25
-29 -13
5 -12
Net Cash Flow -6 -0
Free Cash Flow 2 15
CFO/OP 92% 79%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
Debtor Days 48 49
Inventory Days 155 156
Days Payable 57 39
Cash Conversion Cycle 146 166
Working Capital Days 88 97
ROCE % 30%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
DCP share of net sales
% ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Gelatine share of net sales
% ・Standalone data
Export share of net sales
% ・Standalone data
Top 10 customers share of TOI
% ・Standalone data
DCP sales volume growth
% YoY ・Standalone data
Gelatine sales volume growth
% YoY ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
77.65% 77.65% 77.65% 77.65% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
22.35% 22.34% 22.34% 22.34% 24.99% 24.99% 25.00% 25.00% 24.99% 24.99% 25.00% 24.99%
No. of Shareholders 7,5527,5697,5157,3787,8647,5477,5607,6157,8097,5597,3127,723

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings